Eagle Bay Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5
Closed -$646 936
2023
Q1
$646 Hold
5
﹤0.01% 861
2022
Q4
$638 Hold
5
﹤0.01% 867
2022
Q3
$1K Hold
5
﹤0.01% 887
2022
Q2
$525 Buy
+5
New +$593 ﹤0.01% 996
2022
Q1
Sell
-3
Closed -$1K 999
2021
Q4
$1K Sell
3
-3
-50% -$393 ﹤0.01% 1072
2021
Q3
$0 Buy
6
+3
+100% +$441 ﹤0.01% 1179
2021
Q2
$1K Buy
+3
New +$486 ﹤0.01% 944

Other funds holding ZBH

Eagle Bay Advisors's ZBH Position: Q2 2023 in Review

Eagle Bay Advisors sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 5 shares — an estimated $646 sold.

Eagle Bay Advisors first reported a position in ZBH in Q2 2021 and held it in 7 quarters. The position peaked at $1K in Q3 2022. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • Eagle Bay Advisors reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
  • Eagle Bay Advisors sold 5 Zimmer Biomet shares in Q2 2023, an estimated $646.
  • Eagle Bay Advisors first reported a position in Zimmer Biomet in Q2 2021 and held it in 7 quarters.
  • Eagle Bay Advisors's Zimmer Biomet position peaked at $1K in Q3 2022.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Eagle Bay Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.